Nystatin LF: Began a Phase III U.S. trial

Aronex Pharmaceuticals Inc. (ARNX), The Woodlands, Texas Product: Nystatin LF (liposomal formulation) Indication: Fungal infections Status: Began a Phase III U.S. trial to treat 200 immunocompromised ...